SEC Form 4 · accession 0001645627-17-000147

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · 10% Owner

Period of report

Dec 8, 2017

Accepted (ET)

Dec 19, 2017 · 6:42 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001528172

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Dec 8, 2017	P	3,000	$0.0594	A	24,463,189	D
Common Stock	Dec 8, 2017	P	3,000	$0.055	A	24,466,189	D
Common Stock	Dec 8, 2017	P	3,000	$0.055	A	24,469,189	D
Common Stock	Dec 8, 2017	P	1,000	$0.055	A	24,470,189	D
Common Stock	Dec 11, 2017	P	3,000	$0.059	A	24,473,189	D
Common Stock	Dec 11, 2017	P	3,000	$0.0558	A	24,476,189	D
Common Stock	Dec 11, 2017	P	3,000	$0.055	A	24,479,189	D
Common Stock	Dec 12, 2017	P	3,000	$0.055	A	24,482,189	D
Common Stock	Dec 12, 2017	P	3,000	$0.054	A	24,485,189	D
Common Stock	Dec 12, 2017	P	3,000	$0.058	A	24,488,189	D
Common Stock	Dec 12, 2017	P	3,000	$0.0579	A	24,491,189	D
Common Stock	Dec 13, 2017	P	10,000	$0.056	A	24,501,189	D
Common Stock	Dec 13, 2017	P	3,000	$0.058	A	24,504,189	D
Common Stock	Dec 14, 2017	P	3,000	$0.0562	A	24,507,189	D
Common Stock	Dec 14, 2017	P	3,000	$0.0575	A	24,510,189	D
Common Stock	Dec 15, 2017	P	3,000	$0.0575	A	24,513,189	D
Common Stock	Dec 15, 2017	P	3,000	$0.055	A	24,516,189	D
Common Stock	Dec 15, 2017	P	3,000	$0.055	A	24,519,189	D
Common Stock	Dec 18, 2017	P	3,000	$0.0568	A	24,522,189	D
Common Stock	Dec 18, 2017	P	3,000	$0.055	A	24,525,189	D
Common Stock	Dec 18, 2017	P	3,000	$0.0545	A	24,528,189	D

No Table II lines on this filing.